![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 25, 16431-16435, 09, 1991
RO Juvonen, M Iwasaki and M Negishi
Pharmacogenetics Section, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Residue-209 plays a critical role in determining the substrate and product specificity of cytochrome P450coh. In order to investigate further the structural function of residue-209 in coumarin 7- hydroxylase reaction, we measured the enzyme-kinetic properties of wild- type P450coh and its mutants in which residue-209 was substituted with various amino acids. In general, the Km and Vmax values for coumarin increased as the size of residue-209 became smaller and Vmax values decreased. The size of residue-209, therefore, was a principle factor determining Km, Kd, and Vmax values of P450coh. Although the polarity and charge also increased the Km value consistently, they altered Vmax and Kd values in an irregular manner. The substitution of serine for residue-209 increased the Vmax, while the substitution of lysine decreased it. Coumarin 7-hydroxylase activity was inhibited weakly by indan, but competitively and strongly by 2-coumaranone. Moreover, Ki values for the inhibitor were similar to Km values of the corresponding, mutated P450s. The results indicate, therefore, that residue-209 is localized in a proposed substrate-binding sequence 1 which binds to the 2-keto group of coumarin and directs its 7-position toward the sixth ligand of heme. Consequently, the identity of residue- 209 determines not only the binding of coumarin in P450coh, but also the other reaction step(s) of coumarin 7-hydroxylation.
This article has been cited by other articles:
![]() |
H.-L. Lin, H. Zhang, L. Waskell, and P. F. Hollenberg Threonine-205 in the F Helix of P450 2B1 Contributes to Androgen 16{beta}-Hydroxylation Activity and Mechanism-Based Inactivation J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 744 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, E. E. Scott, H. Liu, and J. R. Halpert A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5 J. Biol. Chem., May 2, 2003; 278(19): 17178 - 17184. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Harlow and J. R. Halpert Alanine-scanning Mutagenesis of a Putative Substrate Recognition Site in Human Cytochrome P450 3A4. ROLE OF RESIDUES 210AND 211IN FLAVONOID ACTIVATION AND SUBSTRATE SPECIFICITY J. Biol. Chem., February 28, 1997; 272(9): 5396 - 5402. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Ibeanu, B. I. Ghanayem, P. Linko, L. Li, L. G. Pedersen, and J. A. Goldstein Identification of Residues 99, 220, and 221 of Human Cytochrome P450 2C19 as Key Determinants of Omeprazole Hydroxylase Activity J. Biol. Chem., May 24, 1996; 271(21): 12496 - 12501. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |